BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9098257)

  • 21. Intraocular pressure increase associated with epsilon-aminocaproic acid therapy for traumatic hyphema.
    Dieste MC; Hersh PS; Kylstra JA; Larrison WI; Frambach DA; Shingleton BJ
    Am J Ophthalmol; 1988 Oct; 106(4):383-90. PubMed ID: 3177553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Traumatic hyphema.
    Crouch ER
    J Pediatr Ophthalmol Strabismus; 1986; 23(2):95-7. PubMed ID: 3958878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epsilon aminocaproic acid for management of traumatic hyphema with large blood clot in the anterior chamber].
    Kotas R; Neumann D; Ashkenazi I
    Harefuah; 1990 Nov; 119(9):269-70. PubMed ID: 2258114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraocular pressure increase associated with traumatic epsilon-aminocaproic acid therapy for traumatic hyphema.
    Romano PE
    Am J Ophthalmol; 1989 May; 107(5):568-70. PubMed ID: 2712150
    [No Abstract]   [Full Text] [Related]  

  • 25. Aminocaproic acid prophylaxis in traumatic hyphema.
    Wilson TW; Jeffers JB; Nelson LB
    Ophthalmic Surg; 1990 Nov; 21(11):807-9. PubMed ID: 2270168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary hemorrhage in traumatic hyphema. Predictive factors for selective prophylaxis.
    Fong LP
    Ophthalmology; 1994 Sep; 101(9):1583-8. PubMed ID: 8090460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aminocaproic acid in the treatment of traumatic hyphema.
    Crouch ER; Frenkel M
    Am J Ophthalmol; 1976 Mar; 81(3):355-60. PubMed ID: 769560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical aminocaproic acid significantly reduces the incidence of secondary hemorrhage in traumatic hyphema in the rabbit model.
    Allingham RR; Crouch ER; Williams PB; Catlin JC; Loewy DM; Jacobson J
    Arch Ophthalmol; 1988 Oct; 106(10):1436-8. PubMed ID: 3178555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Traumatic subtotal hyphema in a child with vitamin K deficiency.
    Levy J; Kapelushnick J; Ravinowitz R; Moser A; Lifshitz T
    Can J Ophthalmol; 2004 Dec; 39(7):790-1. PubMed ID: 15696773
    [No Abstract]   [Full Text] [Related]  

  • 30. Aminocaproic acid reduces the risk of secondary hemorrhage in patients with traumatic hyphema.
    Kutner B; Fourman S; Brein K; Hobson S; Mrvos D; Sheppard J; Weisman S
    Arch Ophthalmol; 1987 Feb; 105(2):206-8. PubMed ID: 3813951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sickle cell trait as a risk factor for secondary hemorrhage in children with traumatic hyphema.
    Nasrullah A; Kerr NC
    Am J Ophthalmol; 1997 Jun; 123(6):783-90. PubMed ID: 9535622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro steroids for systemic antifibrinolytic treatment for traumatic hyphema.
    Romano PE
    J Pediatr Ophthalmol Strabismus; 1986; 23(2):92-5. PubMed ID: 3790203
    [No Abstract]   [Full Text] [Related]  

  • 33. Traumatic hyphema: a critical review of the scientifically catastrophic history of steroid treatment therefore; and A report of 24 additional cases with no rebleeding after treatment with the Yasuna systemic steroid, no touch PLUS protocol.
    Romano PE; Phillips PJ
    Binocul Vis Strabismus Q; 2000; 15(2):187-96. PubMed ID: 10893462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of traumatic hyphema.
    Walton W; Von Hagen S; Grigorian R; Zarbin M
    Surv Ophthalmol; 2002; 47(4):297-334. PubMed ID: 12161209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traumatic hyphema in children.
    Agapitos PJ; Noel LP; Clarke WN
    Ophthalmology; 1987 Oct; 94(10):1238-41. PubMed ID: 3684201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent traumatic hyphema due to increased local fibrinolysis.
    Zehavi H; Kaufman S; Barishak R
    Ophthalmologica; 1980; 180(5):262-6. PubMed ID: 7207964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Traumatic hyphema in a patient with severe hemophilia A: Clinical features and management.
    Belviranli S; Ozkagnici A; Tokgoz H; Bitirgen G; Caliskan U
    Eur J Ophthalmol; 2021 Mar; 31(2):NP106-NP108. PubMed ID: 31187640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rebleeding after traumatic hyphema.
    Thomas MA; Parrish RK; Feuer WJ
    Arch Ophthalmol; 1986 Feb; 104(2):206-10. PubMed ID: 3947294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial.
    Derakhshan A; Firoozi J; Esmaeili S; Bakhtiari E; Abbaspour M; Abrishami M; Zia MJ
    J Fr Ophtalmol; 2022 Jan; 45(1):9-12. PubMed ID: 34949502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin and secondary bleeding after traumatic hyphema.
    Marcus M; Biedner B; Lifshitz T; Yassur Y
    Ann Ophthalmol; 1988 Apr; 20(4):157-8. PubMed ID: 3288070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.